Cutler Group’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-300
Closed -$2K 6321
2017
Q3
$2K Sell
300
-42,300
-99% -$3.2M ﹤0.01% 5235
2017
Q2
$83K Buy
42,600
+41,400
+3,450% +$2.87M ﹤0.01% 2024
2017
Q1
$5K Sell
1,200
-500
-29% -$29.4K ﹤0.01% 4802
2016
Q4
$6K Buy
1,700
+1,200
+240% +$65.9K ﹤0.01% 4816
2016
Q3
$5K Sell
500
-200
-29% -$9.81K ﹤0.01% 5029
2016
Q2
$1K Sell
700
-600
-46% -$27.6K ﹤0.01% 6395
2016
Q1
$9K Buy
+1,300
New +$54.9K ﹤0.01% 4226

Other funds holding PRAH

Cutler Group's PRAH Position: Q3 2018 in Review

Cutler Group sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2018, closing a stake of 56 shares — an estimated $5K sold.

Cutler Group first reported a position in PRAH in Q4 2015 and held it in 9 quarters. The position peaked at $113K in Q3 2016. 342 funds tracked by Wall St. Rank hold PRAH as of Q3 2018.

  • Cutler Group reported no remaining PRA Health Sciences, Inc. position as of Q3 2018 after selling out during the quarter.
  • Cutler Group sold 56 PRA Health Sciences, Inc. shares in Q3 2018, an estimated $5K.
  • Cutler Group first reported a position in PRA Health Sciences, Inc. in Q4 2015 and held it in 9 quarters.
  • Cutler Group's PRA Health Sciences, Inc. position peaked at $113K in Q3 2016.
  • 342 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2018.

Based on Cutler Group's 13F filing for Q3 2018, filed 7 Nov 2018.